Sulzer AG (0QQ9)
London Stock Exchange · UK · prices in GBP · close of 27 Oct 2026
Key indicators
| Last close | GBP 176.90 |
|---|---|
| 52-week range | 128.00 – 180.40 |
| Return, 1 month / 3 months | +16.7% / +23.5% |
| Return, 1 year / 3 years | +31.4% / +141.8% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 29.8% |
| Worst drawdown (1 year) | -25.1% |
| Average daily value traded | 1.04M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sulzer is a Swiss industrial engineering company based in Winterthur. It designs and manufactures pumps and equipment used to move fluids in water, energy and industrial processes, and it provides rotating equipment services that keep machinery running for customers in power, oil and gas, and other heavy industries. The company also supplies surface coating technologies and related components. Its customers are mainly industrial firms, utilities and plant operators around the world who rely on its equipment and maintenance services.
On this site Sulzer AG appears as a stock on the London Stock Exchange (UK), code 0QQ9, with prices in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sulzer AG (0QQ9) trades on the London Stock Exchange in UK. It last closed at GBP 176.90 on 27 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 651 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.4% and over the last three months it rose 23.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.2% | ||
| From 52-week high | -1.2% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.5% | ||
| 6-month return | 19.4% | ||
| 12-month return, skipping the last month | 12.6% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.1% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.04M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.7% |
|---|---|
| 1 month | +16.7% |
| 3 months | +23.5% |
| 6 months | +19.4% |
| 1 year | +31.4% |
| 3 years | +141.8% |
| 5 years | +92.5% |
Signals
| 50-day / 200-day average | 158.30 / 156.28 |
|---|---|
| Golden / death cross (60 days) | Golden, 6 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Apr 2025 | GBX 0.0425 |
| 18 Apr 2024 | GBX 0.0375 |
| 21 Apr 2023 | GBX 0.0350 |
| 8 Apr 2022 | GBX 0.0350 |
| 16 Apr 2021 | GBX 0.0269 |
| 17 Apr 2020 | GBX 0.0269 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.